Publications (23) Publications in which a researcher has participated

filter_list Cancer Research

2022

  1. Gastric metastases with a choriocarcinoma component from a postpuberal teratoma with mature histology

    Revista Espanola de Patologia, Vol. 55, pp. S49-S53

  2. Molecular diagnosis in non-small-cell lung cancer: Expert opinion on ALK and ROS1 testing

    Journal of Clinical Pathology, Vol. 75, Núm. 3, pp. 145-153

  3. Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1

    Journal of Personalized Medicine, Vol. 12, Núm. 5

2021

  1. ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

    Oncogene, Vol. 40, Núm. 16, pp. 2923-2935

  2. High Expression of FOXP2 Is Associated with Worse Prognosis in Glioblastoma

    World Neurosurgery, Vol. 150, pp. e253-e278

2020

  1. Cationic amphiphilic drugs induce elevation in lysoglycerophospholipid levels and cell death in leukemia cells

    Metabolomics, Vol. 16, Núm. 9

  2. Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells

    Carcinogenesis, Vol. 41, Núm. 8, pp. 1113-1122

2019

  1. Correction: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene, (2017), 36, 33, (4802-4809), 10.1038/onc.2017.21)

    Oncogene

2018

  1. Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in Cancer

    Handbook of Experimental Pharmacology (Springer New York LLC), pp. 155-190

2017

  1. DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer

    Oncogene, Vol. 36, Núm. 33, pp. 4802-4809

  2. Erratum: DUB3 and USP7 de-ubiquitinating enzymes control replication inhibitor Geminin: molecular characterization and associations with breast cancer (Oncogene (2017) 36 33 (4802-4809))

    Oncogene

  3. Site-to-site interdomain communication may mediate different loss-of-function mechanisms in a cancer-associated NQO1 polymorphism

    Scientific Reports, Vol. 7

2015

  1. Clinicopathological analysis of factors related to colorectal tumor perforation

    Medicine (United States), Vol. 94, Núm. 15

  2. MTHFR C677T polymorphism and anatomopathological characteristics with prognostic significance in sporadic colorectal cancer

    Pathology Research and Practice, Vol. 211, Núm. 12, pp. 989-995

2014

  1. Intestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDR

    Cancer Medicine, Vol. 3, Núm. 4, pp. 1041-1051

2013

  1. Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability

    International Journal of Colorectal Disease, Vol. 28, Núm. 9, pp. 1187-1193

  2. Metastatic lymphs nodes and lymph node ratio as predictive factors of survival in perforated and non-perforated T4 colorectal tumors

    Journal of Surgical Oncology, Vol. 108, Núm. 3, pp. 176-181

2012

  1. The hMSH2(M688R) lynch syndrome mutation may function as a dominant negative

    Carcinogenesis, Vol. 33, Núm. 9, pp. 1647-1654

2011

  1. Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome

    Familial Cancer, Vol. 10, Núm. 2, pp. 265-271

2007

  1. Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice

    Cancer Research, Vol. 67, Núm. 3, pp. 881-889